Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,475 | 6,247 | 5,608 | 6,758 | 7,779 |
| Receivables | 134 | N/A | N/A | N/A | N/A |
| TOTAL | $5,775 | $6,356 | $5,845 | $6,964 | $7,887 |
| Non-Current Assets | |||||
| PPE Net | 46 | 49 | 55 | 62 | 68 |
| Other Non-Current Assets | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $56 | $60 | $66 | $72 | $79 |
| Total Assets | $5,832 | $6,415 | $5,911 | $7,037 | $7,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106 | 241 | 252 | 88 | 250 |
| Accrued Expenses | 193 | 155 | 199 | 246 | 45 |
| TOTAL | $299 | $396 | $451 | $335 | $294 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15 | 19 | 47 | 47 | 54 |
| TOTAL | $15 | $19 | $47 | $47 | $54 |
| Total Liabilities | $314 | $415 | $499 | $381 | $349 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,655 | 19,395 | 19,395 | 18,043 | 18,043 |
| Common Shares | 19 | 19 | 18 | 18 | 18 |
| Retained earnings | -31,712 | -30,983 | -30,079 | -28,750 | -27,705 |
| TOTAL | $5,518 | $6,001 | $5,412 | $6,655 | $7,618 |
| Total Liabilities And Equity | $5,832 | $6,415 | $5,911 | $7,037 | $7,966 |